Blog
TPA Administration in the Age of Value-Based Care: Adapting to New Payment Models
The Shift from Fee-for-Service to Value-Based Care For decades, the healthcare industry operated under a fee-for-service (FFS) model, where providers were reimbursed for each service rendered—be it a test, procedure, or consultation. This system ofte …
The Rising Cost of Specialty Drugs: 3 Ways Your Medical Practice Can Adapt
A longtime patient comes in for a follow-up, frustrated and exhausted. They’ve spent weeks battling with their insurance company over their specialty medication—only to be told it isn’t covered. The out-of-pocket cost? Almost $4,000 per month. They l …
What to expect in 2025 in 340B, TPA and Infusion Therapy
As we enter 2025, the landscape of healthcare policies is poised for significant transformation. Staying informed is crucial for healthcare administrators and medical professionals, especially those at Federally Qualified Health Centers (FQHCs). Key …
IV Therapy: The Missing Link to Expanding Your Healthcare Services
Imagine reducing hospital admissions, improving chronic disease management, and creating a new revenue stream—all while enhancing patient satisfaction. Sound too good to be true? It’s not. The growing demand for infusion therapy is transforming healt …
3 Predictions for 2025 – Prediction #3: Specialty Pharmacies Will Play a Crucial Role in Patient Education
Over the past two weeks, we’ve explored how the medical landscape is evolving and what these changes mean for healthcare providers, TPAs, and specialty pharmacies. Now, it’s time to dive into our final—and perhaps most transformative—prediction for 2 …
3 Predictions for 2025 – Prediction #2: Increasing Importance of Touchpoints For Ensuring Access and Adherence
In last week’s blog, we unpacked our first big prediction for the 340B and TPA space in 2025—and the insights were just the beginning. The evolving dynamics of healthcare policy, technology, and reimbursement models are setting the stage for a transf …
3 Predictions for 2025 – Prediction #1: Rethinking “Speciality” Medications
As we approach 2025, the 340B Program and the broader healthcare landscape are poised for significant shifts, especially with the planned rollout of changes to the Medicare Prescription Payment Plan. What do these changes mean for current 340B provid …
De-Risking Infusion Therapy: A Profitable Guide to Starting an Infusion Clinic with 340B Support
Infusion therapy is in high demand, particularly for patients with chronic illnesses—from autoimmune disorders to severe infections—who need frequent, reliable treatment to manage their conditions. However, many of these patients either don’t receive …
Breaking: 340B Program Growth Raises Concerns Over Tax Revenue and Medicare Costs
As specialists in 340B, infusions, and TPA consulting, Remy Health is committed to keeping you updated on the latest developments impacting your practice and the patients you serve. A breaking memo from former Congressional Budget Office (CBO) Direct …
340B Infusions: Care Continuity and Cost Savings
Some things are just better together. Like the quality patient care, treatment continuity and direct delivery of necessary medicines that IV infusions provide, with the cost-savings of 340B program discounts. “One of our favorite strategies for impro …
- 1
- 2